Codes / ICD10CM / T83.714S

T83.714S Erosion of implanted ureteral bulking agent to surrounding organ or tissue, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Erosion of implanted ureteral bulking agent to surrounding organ or tissue, sequela

Summary

Erosion of implanted ureteral bulking agent, sequela, refers to the residual effects of the bulking agent wearing through or into adjacent organs or tissues. This condition may result in tissue damage, discomfort, or complications that require ongoing medical evaluation and management.

Causes

The sequela may arise from prior erosion of the ureteral bulking agent, which can be caused by factors such as improper surgical technique, infection, inflammation, or the body's reaction to the material. Over time, physical stress or degradation of the implant may contribute to the original erosion, leading to these long-term effects.

Risk Factors

  • Prior surgeries involving ureteral implants
  • Infections or chronic inflammation
  • Physical activity placing stress on the implant site
  • Smoking or conditions affecting healing
  • Individual sensitivity to foreign materials

Symptoms

  • Persistent pain or discomfort at the implant site
  • Abnormal discharge or bleeding
  • Urinary problems, such as incontinence or urgency
  • Signs of tissue exposure or damage
  • Infection-related symptoms (e.g., fever, redness)

Diagnosis

Diagnosis typically involves a physical examination to assess the implant site and surrounding tissues. Imaging studies like ultrasound or MRI may be used to evaluate the extent of residual erosion. Additional procedures, such as cystoscopy, might be performed for detailed assessment of affected tissues or organs.

Treatment Options

Treatment may include non-surgical management, such as monitoring or symptom relief, or surgical intervention to address tissue damage or remove the eroded material. The approach depends on the severity of symptoms and the extent of tissue involvement.

Prognosis and Follow-Up

Prognosis varies based on the extent of tissue damage and response to treatment. Regular follow-up is important to monitor for complications or recurrence. Long-term management may be necessary to address persistent symptoms or functional issues.

Complications

  • Chronic pain or discomfort
  • Infection or abscess formation
  • Urinary tract dysfunction
  • Tissue damage requiring further surgery
  • Reduced quality of life due to symptoms

Lifestyle & Prevention

  • Avoid activities that place excessive stress on the implant site
  • Maintain good hygiene to reduce infection risk
  • Follow post-surgical care instructions
  • Report new or worsening symptoms promptly
  • Discuss smoking cessation with a healthcare provider if applicable

When to Seek Professional Help

Seek medical attention if you experience persistent pain, abnormal bleeding, signs of infection, or worsening urinary symptoms. Early evaluation can help prevent further complications.

Tips for Medical Coders

When coding T83.714S, ensure documentation supports the sequela of erosion of an implanted ureteral bulking agent. Verify that the condition is linked to a prior erosion event and that the current status reflects residual effects. Include details about the affected organ or tissue and any ongoing management or complications.

Book a walkthrough

T83.714S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.